Paper37568720
Interruption of p53-MDM2 Interaction by Nutlin-3a in Human Lymphoma Cell Models Initiates a Cell-Dependent Global Effect on Transcriptome and Proteome Level.
Psatha K and 8 others. Cancers (Basel), 2023. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Interruption of p53-MDM2 Interaction by Nutlin-3a in Human Lymphoma Cell Models Initiates a Cell-Dependent Global Effect on Transcriptome and Proteome Level. Papers, record 37568720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37568720
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Interruption of p53-MDM2 Interaction by Nutlin-3a in Human Lymphoma Cell Models Initiates a Cell-Dependent Global Effect on Transcriptome and Proteome Level.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| SNF0031 | Stavros Niarchos Foundation | PubMed | ||
| ΨΤΠΔ4653ΠΣ-7ΩΔ | STATE SCHOLARSHIPS FOUNDATION (IKY) | PubMed |
Source PubMed
References95
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21484514 | Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma. | Angiogenesis | 2011 | https://conductscience.org/library/papers/21484514 | PubMed |
| 2 | 17444671 | Large-scale identification of N-terminal peptides in the halophilic archaea Halobacterium salinarum and Natronomonas pharaonis. | J Proteome Res | 2007 | https://conductscience.org/library/papers/17444671 | PubMed |
| 3 | 19788889 | DNA damage response to the Mdm2 inhibitor nutlin-3. | Biochem Pharmacol | 2010 | https://conductscience.org/library/papers/19788889 | PubMed |
| 4 | 26216070 | Integration of Proteomics and Transcriptomics Data Sets for the Analysis of a Lymphoma B-Cell Line in the Context of the Chromosome-Centric Human Proteome Project. | J Proteome Res | 2015 | https://conductscience.org/library/papers/26216070 | PubMed |
| 5 | 21149340 | Cytoscape 2.8: new features for data integration and network visualization. | Bioinformatics | 2011 | https://conductscience.org/library/papers/21149340 | PubMed |
| 6 | 21562588 | Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors. | Cell Death Dis | 2011 | https://conductscience.org/library/papers/21562588 | PubMed |
| 7 | 23039052 | An iTRAQ proteomics screen reveals the effects of the MDM2 binding ligand Nutlin-3 on cellular proteostasis. | J Proteome Res | 2012 | https://conductscience.org/library/papers/23039052 | PubMed |
| 8 | 17957188 | MLL translocations, histone modifications and leukaemia stem-cell development. | Nat Rev Cancer | 2007 | https://conductscience.org/library/papers/17957188 | PubMed |
| 9 | 19225536 | Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma. | Leukemia | 2009 | https://conductscience.org/library/papers/19225536 | PubMed |
| 10 | 25574629 | PeptideShaker enables reanalysis of MS-derived proteomics data sets. | Nat Biotechnol | 2015 | https://conductscience.org/library/papers/25574629 | PubMed |
| 11 | 21338495 | A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation. | BMC Cancer | 2011 | https://conductscience.org/library/papers/21338495 | PubMed |
| 12 | 22064349 | Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia. | Leukemia | 2012 | https://conductscience.org/library/papers/22064349 | PubMed |
| 13 | 19670246 | Life-style changes of a halophilic archaeon analyzed by quantitative proteomics. | Proteomics | 2009 | https://conductscience.org/library/papers/19670246 | PubMed |
| 14 | 26122615 | p53 in survival, death and metabolic health: a lifeguard with a licence to kill. | Nat Rev Mol Cell Biol | 2015 | https://conductscience.org/library/papers/26122615 | PubMed |
| 15 | 16428504 | Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16428504 | PubMed |
| 16 | 16483782 | Heat shock proteins in cancer: chaperones of tumorigenesis. | Trends Biochem Sci | 2006 | https://conductscience.org/library/papers/16483782 | PubMed |
| 17 | 15489903 | The interaction of p53 with replication protein A mediates suppression of homologous recombination. | Oncogene | 2004 | https://conductscience.org/library/papers/15489903 | PubMed |
| 18 | 24650973 | Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma. | Clin Lymphoma Myeloma Leuk | 2014 | https://conductscience.org/library/papers/24650973 | PubMed |
| 19 | 10672275 | Interactions of chloromethyltetramethylrosamine (Mitotracker Orange) with isolated mitochondria and intact cells. | Ann N Y Acad Sci | 1999 | https://conductscience.org/library/papers/10672275 | PubMed |
| 20 | 24871945 | APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction. | Dev Cell | 2014 | https://conductscience.org/library/papers/24871945 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41282624 | Anticancer activity of MDM2 inhibition in 2D and bioprinted 3D retinoblastoma cell models. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41282624 | PubMed |
| 41050051 | Gastric Adenocarcinoma in a Pregnant Woman at 33 Weeks of Gestation: A Case Report of Krukenberg Tumor Complicated by Uterine Rupture. | Cureus | 2025 | https://conductscience.org/library/papers/41050051 | PubMed |
| 40191727 | p53: A player in the tumor microenvironment. | Oncol Res | 2025 | https://conductscience.org/library/papers/40191727 | PubMed |
| 40104186 | Future of non-invasive graft evaluation: A systematic review of proteomics in kidney transplantation. | World J Transplant | 2025 | https://conductscience.org/library/papers/40104186 | PubMed |
| 40031988 | Harnessing p53 for targeted cancer therapy: new advances and future directions. | Transcription | 2025 | https://conductscience.org/library/papers/40031988 | PubMed |
| 39202022 | Integrative Analysis of Multi-Omics Data to Identify Deregulated Molecular Pathways and Druggable Targets in Chronic Lymphocytic Leukemia. | J Pers Med | 2024 | https://conductscience.org/library/papers/39202022 | PubMed |
| 38731863 | Characterization of Human B Cell Hematological Malignancies Using Protein-Based Approaches. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38731863 | PubMed |
| 38521878 | The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer. | J Cancer Res Clin Oncol | 2024 | https://conductscience.org/library/papers/38521878 | PubMed |
Genes156
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37568720
GET https://conductscience.org/api/papers/v1/37568720/references?page=2